NATURE OF THE ORGANIZATION AND BUSINESS (Details Narrative) - USD ($)					3 Months Ended
	Jun. 07, 2024	Dec. 12, 2023	Sep. 26, 2023	Mar. 21, 2023	Mar. 31, 2025	Jun. 30, 2024	Mar. 31, 2024	May 05, 2025	Dec. 31, 2024	Dec. 11, 2023	Jul. 15, 2021	Feb. 22, 2021	Apr. 25, 2019	Jun. 30, 2018	Apr. 01, 2016
Common stock per share					$ 0.01				$ 0.01			$ 0.01
Accumulated deficit					$ 235,644,977				$ 236,253,218
Cash on hand					34,393,410				35,004,924
Proceeds from collaboration					10,000,000
Medifast Inc [Member]
Collaboration amount		$ 5,000,000							$ 10,000,000	$ 10,000,000
Consideration to be transferred						$ 2,500,000	$ 2,500,000
Subsequent Event [Member]
Cash								$ 24,500,000
ATM Sales Agreement [Member]
Proceeds from issuance of common stock	$ 53,300,000
Proceeds from sale of securities	53,300,000				53,300,000
2024 Shelf [Member]
Proceeds from sale of securities					150,000,000.0
Medifast Private Placement [Member]
Shares issued		1,224,425
Shares issued per share		$ 8.1671
Proceeds		$ 10,000,000
Shares and Securities [Member]
Raise up funds	$ 150,000,000.0
Avenue Facility [Member]
Credit facility				$ 40,000,000	2,000,000
Proceeds from line of credit			$ 5,000,000	15,000,000
Uncommitted term loans				20,000,000
Warrants to purchase				$ 1,200,000
Warrants exercise price				$ 1.24
Debt conversion amount				$ 2,000,000
Conversion price				$ 1.49
Line of credit, description				The Company is subject to certain affirmative and negative covenants under the Avenue Facility, including the requirement, beginning on the closing date, to maintain at least $5 million of unrestricted cash to be tested at the end of each month, and beginning on the period ended September 30, 2023, and at the end of each quarter thereafter, a trailing six-month cash flow, subject to certain adjustments as provided by the Avenue Credit Agreement, of at least $2 million.
Credit facility outstanding					$ 19,000,000
Credit facility interest rate description					(i) the sum of 4.75% plus the Prime Rate (as defined in the Avenue Supplement) and (ii) 12.50%. Payments are interest only for up to 24 months and then fully amortized thereafter.
Line of credit, expiration date				Oct. 01, 2026
Avenue Facility [Member] | Minimum [Member]
Credit facility interest rate					1.00%
Avenue Facility [Member] | Maximum [Member]
Credit facility interest rate					3.00%
LegalSimpli Software, LLC [Member]
Voting interests acquired														51.00%
Immudyne PR LLC [Member]
Equity method investment, ownership percentage															78.20%
Conversion Labs PR [Member]
Equity method investment, ownership percentage													100.00%
WorkSimpli Software LLC [Member]
Equity method investment, ownership percentage											73.30%